GitLab Analysts Slash Their Forecasts After Q1 Results - GitLab ( NASDAQ:GTLB )
GitLab, Inc. GTLB posted better-than-expected first-quarter results and issued second-quarter sales guidance with its midpoint below estimates on Tuesday. GitLab reported quarterly earnings of 17 cents per share, which beat the analyst consensus estimate of 15 cents.
Heterosexual Awesomeness Festival Announces Headline Band Michael Austin and Key Sponsor United Rentals
BOISE, Idaho, June 11, 2025 /PRNewswire/ -- The Heterosexual Awesomeness Festival, a vibrant celebration of traditional family values, is set to take place on June 20-21, 2025, in Boise, Idaho.
Cantor Fitzgerald, Wall Street Companies Will Lower Crypto Lending Costs, SALT CEO Says
Owen stresses that post-2022 trust rebuild requires transparency in rehypothecation and clearer regulatory licensing frameworks for lenders. Crypto-native lenders must offer tailored risk tools and trust as banks move in to tap digital asset yields. Ready to turn the market's comeback into ...
Fiera Capital Selected by ATB Investment Management Inc. to manage the ATB US Large Cap Equity Fund
MONTREAL, June 11, 2025 /CNW/ - Fiera Capital Corporation FSZ ( "Fiera Capital" ) , a leading independent asset-management firm, today announced that it has been selected by ATB Investment Management Inc. ( "ATBIM" ) , the asset management arm of ATB Financial, to manage the ATB US Large Cap ...
These Analysts Cut Their Forecasts On JM Smucker After Q4 Results - JM Smucker ( NYSE:SJM )
The J. M. Smucker Company SJM reported mixed fourth-quarter financial results and issued FY26 adjusted EPS guidance below estimates on Tuesday. JM Smucker reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $2.24 per share.
PESG Research Update: PolyPid SHIELD's II Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary and secondary endpoints in preventing surgical site infections ( SSIs ) .
Elon Musk Says Some Comments About Donald Trump 'Went Too Far' - And Polymarket Traders Think DJT May Accept The Olive Branch - Tesla ( NASDAQ:TSLA )
Elon Musk says he "went too far" in his recent remarks about Donald Trump. Polymarket odds for a public reconciliation between Musk and Trump spike to 70%. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre on Wednesday, June 11.
PESG Research Update: PolyPid's SHIELD II Trial Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary and secondary endpoints in preventing surgical site infections ( SSIs ) .
ATIS Strengthens Executive Team with Strategic Appointments to Accelerate Growth
ST. LOUIS, June 11, 2025 ( GLOBE NEWSWIRE ) -- ATIS, one of North America's leading providers of vertical transportation consulting, inspections, and managed services, is proud to announce two key executive appointments that reflect the company's continued commitment to innovation and growth.
Academy Sports and Outdoors Analysts Lower Their Forecasts Following Q1 Results - Academy Sports ( NASDAQ:ASO )
Academy Sports and Outdoors, Inc. ASO reported downbeat first-quarter results on Tuesday. The company reported quarterly adjusted earnings per share of 76 cents, missing the analyst consensus estimate of 90 cents. Net sales of $1.35 billion missed the Street view of $1.37 billion.





